WO2020216385A3 - 血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用 - Google Patents

血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用 Download PDF

Info

Publication number
WO2020216385A3
WO2020216385A3 PCT/CN2020/097041 CN2020097041W WO2020216385A3 WO 2020216385 A3 WO2020216385 A3 WO 2020216385A3 CN 2020097041 W CN2020097041 W CN 2020097041W WO 2020216385 A3 WO2020216385 A3 WO 2020216385A3
Authority
WO
WIPO (PCT)
Prior art keywords
exosome
circ
application
diagnosis
serum
Prior art date
Application number
PCT/CN2020/097041
Other languages
English (en)
French (fr)
Other versions
WO2020216385A2 (zh
Inventor
彭英
刘云云
Original Assignee
中山大学孙逸仙纪念医院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中山大学孙逸仙纪念医院 filed Critical 中山大学孙逸仙纪念医院
Priority to US17/600,110 priority Critical patent/US20220154279A1/en
Publication of WO2020216385A2 publication Critical patent/WO2020216385A2/zh
Publication of WO2020216385A3 publication Critical patent/WO2020216385A3/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

一种血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用。所述的外泌体hsa_circ_0004771的表达水平与AD的严重程度#关，可作为标志物用于AD诊断及其严重程度评估。通过血清circRNA标志物刼诊*jf试剂盒的研制和应用，可以使得AD的诊断更加方便易行，为发现具有潜在治疗价值的新型小分子药物靶标提供帮助。
PCT/CN2020/097041 2019-04-22 2020-06-19 血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用 WO2020216385A2 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/600,110 US20220154279A1 (en) 2019-04-22 2020-06-19 Use of serum exosomal hsa_circ_0004771 in preparing reagents for diagnosis of alcohol dependence

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910323834.9 2019-04-22
CN201910323834.9A CN110157792A (zh) 2019-04-22 2019-04-22 血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用

Publications (2)

Publication Number Publication Date
WO2020216385A2 WO2020216385A2 (zh) 2020-10-29
WO2020216385A3 true WO2020216385A3 (zh) 2020-12-17

Family

ID=67639896

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/097041 WO2020216385A2 (zh) 2019-04-22 2020-06-19 血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用

Country Status (3)

Country Link
US (1) US20220154279A1 (zh)
CN (1) CN110157792A (zh)
WO (1) WO2020216385A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110157792A (zh) * 2019-04-22 2019-08-23 中山大学孙逸仙纪念医院 血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用
CN114921553A (zh) * 2022-06-14 2022-08-19 中国医科大学附属第一医院 人脑胶质瘤标志物hsa_circ_0009362及其应用
CN115992217B (zh) * 2022-09-30 2023-09-22 中国人民解放军总医院第二医学中心 用于诊断乳腺癌化疗导致的心肌损伤的环状rna标志物、试剂盒及其应用

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067763A2 (en) * 2003-01-27 2004-08-12 The Regents Of The University Of Colorado, A Body Corporate Genetic diagnosis of alcoholism subtypes
CN1732261A (zh) * 2002-12-24 2006-02-08 日东纺绩株式会社 用于诊断肝脏疾病的标志蛋白质以及使用该蛋白质诊断肝脏疾病的方法
WO2013182912A2 (en) * 2012-06-06 2013-12-12 Fundacio Privada Institut De Recerca Biomedica Method for the diagnosis, prognosis and treatment of lung cancer metastasis
CN103981271A (zh) * 2014-05-26 2014-08-13 中南大学 血清Exosomes来源的长链非编码RNA LINC00470的应用方法
WO2017059451A1 (en) * 2015-10-02 2017-04-06 Complexa, Inc. Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids
CN107034305A (zh) * 2017-06-19 2017-08-11 上海市第十人民医院 恶性胶质瘤的一种诊断标志物
CN107058596A (zh) * 2017-06-19 2017-08-18 上海市第十人民医院 一种与恶性胶质瘤诊断相关的标志物及其应用
CN107365852A (zh) * 2017-08-14 2017-11-21 江苏为真生物医药技术股份有限公司 血清外泌体中肺癌相关microRNA分子标记的应用及其检测试剂盒
CN107557498A (zh) * 2017-10-30 2018-01-09 南京医科大学第附属医院 RelA基因rs11820062SNP在制备检测丙型肝炎易感性产品中的应用
CN110157792A (zh) * 2019-04-22 2019-08-23 中山大学孙逸仙纪念医院 血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101437960A (zh) * 2006-03-01 2009-05-20 佩勒根科学有限公司 成瘾性的标志物
CA2912665C (en) * 2013-05-15 2021-03-02 Robert Kruse Intracellular translation of circular rna
CN104714029A (zh) * 2015-03-04 2015-06-17 华中科技大学 糖尿病患者认知障碍的血清学标志物-GSK3β的检测方法
CN107586846A (zh) * 2017-10-27 2018-01-16 中南大学湘雅医院 胶质瘤诊断标志物Circ3:129880309|129880559及应用
CN108165613A (zh) * 2017-12-26 2018-06-15 上海英拜生物科技有限公司 一种检测外泌体tRFRNA的方法
CN109207425A (zh) * 2018-09-29 2019-01-15 中国医科大学附属口腔医院 牙龈卟啉单胞菌诱导巨噬细胞外泌体rna表达研究方法
CN109280706A (zh) * 2018-12-11 2019-01-29 宁夏医科大学总医院 一种环状RNA hsa-circ-0102618及其特异性扩增引物和应用

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1732261A (zh) * 2002-12-24 2006-02-08 日东纺绩株式会社 用于诊断肝脏疾病的标志蛋白质以及使用该蛋白质诊断肝脏疾病的方法
WO2004067763A2 (en) * 2003-01-27 2004-08-12 The Regents Of The University Of Colorado, A Body Corporate Genetic diagnosis of alcoholism subtypes
WO2013182912A2 (en) * 2012-06-06 2013-12-12 Fundacio Privada Institut De Recerca Biomedica Method for the diagnosis, prognosis and treatment of lung cancer metastasis
CN103981271A (zh) * 2014-05-26 2014-08-13 中南大学 血清Exosomes来源的长链非编码RNA LINC00470的应用方法
WO2017059451A1 (en) * 2015-10-02 2017-04-06 Complexa, Inc. Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids
CN107034305A (zh) * 2017-06-19 2017-08-11 上海市第十人民医院 恶性胶质瘤的一种诊断标志物
CN107058596A (zh) * 2017-06-19 2017-08-18 上海市第十人民医院 一种与恶性胶质瘤诊断相关的标志物及其应用
CN107365852A (zh) * 2017-08-14 2017-11-21 江苏为真生物医药技术股份有限公司 血清外泌体中肺癌相关microRNA分子标记的应用及其检测试剂盒
CN107557498A (zh) * 2017-10-30 2018-01-09 南京医科大学第附属医院 RelA基因rs11820062SNP在制备检测丙型肝炎易感性产品中的应用
CN110157792A (zh) * 2019-04-22 2019-08-23 中山大学孙逸仙纪念医院 血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"PREDICTED: Pan Troglodytes Nuclear Receptor Interacting Protein 1 (NRIP1), Transcript Variant X15, misc_RNA", GENBANK: XR_001712401.2, 20 March 2018 (2018-03-20), DOI: 20200904104207 *

Also Published As

Publication number Publication date
WO2020216385A2 (zh) 2020-10-29
CN110157792A (zh) 2019-08-23
US20220154279A1 (en) 2022-05-19

Similar Documents

Publication Publication Date Title
WO2020216385A3 (zh) 血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用
Yang et al. Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice
Olsen et al. Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules
Fukutomi et al. Serological diagnosis of allergic bronchopulmonary mycosis: Progress and challenges
WO2015071876A3 (en) Use of microrna markers for diagnosis of thyroid tumors and a diagnostic panel containing such markers.
WO2004103150A3 (en) Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
Zhang et al. Bonding to glass ionomer cements using resin-based adhesives
CN103353521B (zh) 直读便携式血糖仪测定生物标志物及dna含量的方法
Guo et al. RETRACTED ARTICLE: Ginkgolide B ameliorates myocardial ischemia reperfusion injury in rats via inhibiting endoplasmic reticulum stress
CN104198731B (zh) 一种c反应蛋白半定量检测试剂及应用该试剂的试纸
Goertz et al. Outcome analysis of liver stiffness by ARFI (acoustic radiation force impulse) elastometry in patients with chronic viral hepatitis B and C
Bloch et al. MiR-181a: a potential biomarker of acute muscle wasting following elective high-risk cardiothoracic surgery
Osawa et al. Postmortem diagnosis of fatal anaphylaxis during intravenous administration of therapeutic and diagnostic agents: evaluation of clinical laboratory parameters and immunohistochemistry in three cases
Zeng et al. Versatile near-infrared fluorescent probe for in vivo detection of Aβ oligomers
Guo et al. Autophagy inhibition protects from alveolar barrier dysfunction in LPS-induced ALI mice by targeting alveolar epithelial cells
Chivate et al. Procalcitonin as a marker for the diagnosis of sepsis
Greenberger Allergic bronchopulmonary aspergillosis.
Yang et al. AP39 inhibits ferroptosis by inhibiting mitochondrial autophagy through the PINK1/parkin pathway to improve myocardial fibrosis with myocardial infarction
Araya et al. Combined dexamethasone and desmopressin test in the differential diagnosis of ACTH-dependent Cushing’s syndrome and pseudo-cushing’s states
JP2014132863A (ja) 神経変性疾患バイオマーカー
RU2013156363A (ru) Диагностика инфекционного заболевания дыхательных путей с использованием образцов крови
Zhang et al. Controlled decompression alleviates brain injury via attenuating oxidative damage and neuroinflammation in acute intracranial hypertension
CN1553190A (zh) 一种用于诊断早期卵巢癌的四粘蛋白酶联免疫检测试剂盒
RU2694097C1 (ru) Способ диагностики абсцесса брюшной полости и забрюшинной флегмоны у больных с панкреонекрозом
ES2481517A2 (es) Método para el diagnóstico de la enfermedad de parkinson en estadios tempranos

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20795864

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20795864

Country of ref document: EP

Kind code of ref document: A2